| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 08/23/2001 | WO2001060804A1 Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid |
| 08/23/2001 | WO2001060803A1 Fused imidazolium derivatives |
| 08/23/2001 | WO2001008668A3 Use of 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine in the treatment of gi disorders |
| 08/23/2001 | WO2000063176A3 Disubstituted pyridines and pyrimidines as herbicides and fungicides |
| 08/23/2001 | US20010016588 Antiallergens; antitumor agents; anticancer agents |
| 08/23/2001 | US20010016238 Electrooptical liquid crystal system |
| 08/23/2001 | DE10038110A1 Pharmazeutische Zusammensetzungen Pharmaceutical compositions |
| 08/22/2001 | EP1125931A1 Biocidal alkyl-substituted-(hetero)aryl-ketoxime-O-ethers and the production method thereof |
| 08/22/2001 | EP1124830A1 Pyrimidin-4-enamine as fungicide |
| 08/22/2001 | EP1124807A1 Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 08/22/2001 | EP1124805A1 Method for producing 4-[(2',5'- diamino-6'- halopyrimidine- 4'-yl)amino]- cyclopent- 2-enylmethanols |
| 08/22/2001 | EP1124560A1 Use of antifungal agents for treating scleroses |
| 08/22/2001 | EP0785926B1 Carboxylic acid derivatives, their preparation and their use as medicaments |
| 08/22/2001 | EP0752854B1 Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments |
| 08/22/2001 | CN1309656A Thioalkyl alpha-substd. pyrimidine compounds |
| 08/22/2001 | CN1309647A Substd. 6-benzyl-4-oxopyrimidines, process for their preparation and pharmaceutical compositions contg. them |
| 08/22/2001 | CN1309646A Di- or tri-fluoromethanesulfonyl anilide derivs., process for preparation of them and herbicides contg. them as active ingredient |
| 08/22/2001 | CN1309634A Hydrazine derivs. |
| 08/22/2001 | CN1069813C 1-[[o-(cyclopropylcarbonyl)-phenyl]sulfamoyl]-3-(4,6-dimethoxy-2-pyrimidinyl) urea as herbicide |
| 08/21/2001 | US6277989 Quinazoline derivatives as medicaments |
| 08/21/2001 | US6277987 Sulfonylamino acid and sulfonylamino hydroxamic acid derivatives |
| 08/21/2001 | US6277858 For protection of plants against infestation by phytopathogenic microorganisms, i.e., fungi |
| 08/21/2001 | US6277849 N-sulphonyl and N-sulphinyl amino acid amides as microbiocides |
| 08/21/2001 | US6277845 Hydrazono-benzazulene derivatives, pharmaceutical compositions and intermediates |
| 08/21/2001 | US6277840 Antiinflammatory agents |
| 08/21/2001 | US6277789 Substituted phenyluracils |
| 08/21/2001 | CA2039855C Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases |
| 08/21/2001 | CA2013324C Pteridin-4(3h)-ones, process for their preparation and drugs containing them |
| 08/16/2001 | WO2001059067A2 A group of anti-cancer compounds with specific structure and their production method |
| 08/16/2001 | WO2001058883A1 Method for the production of 1-amino-3-aryl-uracils |
| 08/16/2001 | WO2001058882A1 Use of pyrimidine endothelin antagonists in companion animals |
| 08/16/2001 | WO2001058881A1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 08/16/2001 | WO2001058853A1 Dehydroamino acids |
| 08/16/2001 | WO2001058852A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils |
| 08/16/2001 | WO2001058843A1 Process for preparing optically active secondary alcohols having nitrogenous or oxygenic functional groups |
| 08/16/2001 | WO2001058454A1 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor |
| 08/16/2001 | WO2001010842A3 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 08/16/2001 | WO2001010385A3 1,4-substituted 4,4-diaryl cyclohexanes |
| 08/16/2001 | WO2001009096A3 Potassium channel openers |
| 08/16/2001 | US20010014694 Hypotensive agents, stroke, vision defects, kidney disorders |
| 08/16/2001 | US20010014688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 08/16/2001 | US20010014679 Animal growth regulator; controlling cell differentiation, gene expression, glucose metabolism, protein metabolism |
| 08/16/2001 | EP1123280A1 Serine protease inhibitor |
| 08/16/2001 | EP1123272A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 08/16/2001 | EP1035851B1 Endothelin receptor antagonists for combating hyperlipidaemia |
| 08/16/2001 | EP0733045B1 4,6-dianilino-pyrimidine derivatives, their preparation and their use as tyrosine kinase inhibitors |
| 08/16/2001 | CA2399421A1 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor |
| 08/16/2001 | CA2398923A1 A group of anti-cancer compounds with specific structure and their production method |
| 08/16/2001 | CA2398007A1 Use of pyrimidine endothelin antagonists in companion animals |
| 08/16/2001 | CA2397993A1 Dehydroamino acids |
| 08/15/2001 | CN1308615A Substituted acylamino phenyl uracils |
| 08/15/2001 | CN1308606A Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use pharmaceutical preparations comprising them |
| 08/15/2001 | CN1308536A Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 08/15/2001 | CA2337381A1 Compositions and methods for treating osteoporosis |
| 08/14/2001 | US6274734 Process for making pyrimidine derivatives |
| 08/14/2001 | US6274733 Process and intermediates in the synthesis of 5-(3-[exo-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyphenyl)-3,4,5,6-tetrahydro-pyrimidin-2(1H)-one |
| 08/14/2001 | US6274732 Alkylation |
| 08/14/2001 | US6274630 Administering polyamine |
| 08/14/2001 | US6274588 4-phenyl-pyrimidine derivatives |
| 08/14/2001 | US6274585 Benign prostatic hyperplasia treatment |
| 08/14/2001 | US6274383 Methods for synthesizing libraries of dihydro-quinazolinones |
| 08/14/2001 | CA2162838C Process for preparing an alkylimidazolidone (meth)acrylate |
| 08/14/2001 | CA2159640C Second messenger cell signaling inhibitors |
| 08/09/2001 | WO2001057037A1 Platelet adp receptor inhibitors |
| 08/09/2001 | WO2001057025A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 08/09/2001 | WO2001056555A2 Use of cox-2 inhibitors for the treatment of constipation |
| 08/09/2001 | WO2001056358A2 Enhanced propertied pesticides |
| 08/09/2001 | WO2001018004A3 PYRAZOLO[4,3-d]PYRIMIDINES |
| 08/09/2001 | WO2001010834A9 Antibacterial agents |
| 08/09/2001 | WO2000071506A3 Naphthalene ureas as glucose uptake enhancers |
| 08/09/2001 | WO2000047554A3 INHIBITORS OF FACTOR Xa |
| 08/09/2001 | US20010012844 Quinazoline, nitrothiazole and indolinone based hydrophobic formulations for oral administration for treating cell proliferation disorder in a mammal |
| 08/09/2001 | DE10061212A1 Verfahren zur Herstellung heterocyclischer Verbindungen Process for the preparation of heterocyclic compounds |
| 08/09/2001 | DE10005284A1 1-Amino-3-phenyl-uracil preparation in high yield, for use as agrochemical or intermediate, by aminating 3-phenyl-uracil with 2-aminooxysulfonyl-1,3,5-trimethylbenzene |
| 08/08/2001 | EP1122244A1 Uracil compounds and their use |
| 08/08/2001 | EP1121342A1 Diaminopropionic acid derivatives |
| 08/08/2001 | EP1121130A2 Zinc finger-reactive antimicrobial compounds |
| 08/08/2001 | EP1121129A1 METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND COMBINATION |
| 08/08/2001 | CN1307564A Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 08/08/2001 | CN1307501A Complexes of ultraviolet absorbers and quaternary ammonium compounds which are substantially free from unwanted salts |
| 08/07/2001 | USRE37314 Pyrimidine derivatives |
| 08/07/2001 | US6271376 Process for the preparation of N-(amino-4,6-dihalo-pyrimidine) formamides |
| 08/07/2001 | US6271374 Stable crystalline (6S)- and (6R)-tetrahydrofolic acid |
| 08/07/2001 | US6271357 Oligonucleotide mimics having nitrogen-containing linkages |
| 08/07/2001 | US6271247 Binding to neuropeptide receptors |
| 08/07/2001 | US6271238 Useful in treating and preventing diseases involving chymotrypsin type proteases which are related to asthma, allergy, inflammations, rheumatism, hypertension, heart failure, myocardial infarction, and cardiac hypertrophy |
| 08/07/2001 | US6271212 Mixture with carrier |
| 08/04/2001 | CA2646796A1 Hydroxypyridine compounds useful as intermediates |
| 08/02/2001 | WO2001055148A1 Pyridopyrimidinone derivatives for treatment of neurodegenerative disease |
| 08/02/2001 | WO2001055120A1 Preparation of sulfonamides |
| 08/02/2001 | WO2001055119A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 08/02/2001 | WO2001055115A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2001 | WO2001055111A1 Biaryl compounds, their preparation and their use in therapy |
| 08/02/2001 | WO2001055082A2 Intermediates for biologically active compounds |
| 08/02/2001 | WO2001054694A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method |
| 08/02/2001 | WO2001054691A1 Nitrate salts of antimicrobial agents |
| 08/02/2001 | WO2001054669A1 Pharmaceutical compositions comprising a hmg coa reductase inhibitor |
| 08/02/2001 | WO2001054668A1 Pharmaceutical compositions comprising a hmg reductase inhibitor |
| 08/02/2001 | WO2001054481A2 Enhanced propertied pharmaceuticals |
| 08/02/2001 | WO2001016114A3 Heterocyclic compounds and methods for modulating cxcr3 function |